首页> 美国卫生研究院文献>other >Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients

【2h】

Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients

机译：患者与非乔-1抗氨酰tRNa合成酶抗体比乔-1阳性患者更差的存活

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectiveTo compare the cumulative survival and event free survival in patients with Jo-1 versus non-Jo-1 anti-tRNA synthetase autoantibodies (anti-synAb).

机译：目的比较Jo-1和非Jo-1抗tRNA合成酶自身抗体（anti-synAb）患者的累积生存率和无事件生存率。

著录项

期刊名称 other
作者
Rohit Aggarwal; Elaine Cassidy; Noreen Fertig; Diane Carol Koontz; Mary Lucas; Dana P Ascherman; Chester V Oddis;
展开▼
作者单位

展开▼
年(卷),期 -1(73),1
年度 -1
页码 227–232
总页数 15
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients [J] . AggarwalR., CassidyE., FertigN., Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2014,第1期

机译：非Jo-1抗tRNA合成酶自身抗体的患者的生存期比Jo-1阳性患者差
2. Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients [J] . AggarwalR., CassidyE., FertigN., Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2014,第1期

机译：非Jo-1抗tRNA合成酶自身抗体的患者的生存期比Jo-1阳性患者差
3. Autoantibody status in systemic sclerosis patients defines both cancer risk and survival with ANA negativity in cases with concomitant cancer having a worse survival [J] . Abdulla Watad, Dennis McGonagle, Nicola L. Bragazzi, Oncoimmunology. . 2019,第6期

机译：系统性硬化症患者的自身抗体状况在伴随癌症患者存活的情况下使用ANA消极性定义癌症风险和生存率
4. Survival prediction of squamous cell head and neck cancer patients based on radiomic features selected from lung cancer patients using artificial neural network [C] . H. Kamezawa, H. Arimura, M. Soufi SPIE Medical Imaging Conference . 2018

机译：利用人工神经网络从肺癌患者的放射学特征中预测鳞状细胞癌的生存率
5. Defining Clinical and Autoantibody Phenotypes in Patients with Juvenile Idiopathic Inflammatory Myopathies. [D] . Shah, Mona N. 2012

机译：定义青少年特发性炎症性肌病患者的临床和自身抗体表型。
6. Autoantibody status in systemic sclerosis patients defines both cancer risk and survival with ANA negativity in cases with concomitant cancer having a worse survival [O] . Abdulla Watad, Dennis McGonagle, Nicola L. Bragazzi, 2019

机译：全身性硬化症患者的自身抗体状况通过伴有ANA阴性的癌症患者的生存率较差的情况确定了癌症风险和生存率
7. Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients [O] . Rohit Aggarwal, Elaine Cassidy, Noreen Fertig, 2013

机译：患有非jo-1抗TRNA合成酶自身抗体的患者比JO-1阳性患者更差

Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients

摘要

著录项

相似文献

相关主题

期刊订阅